Abbott Laboratories logo

Abbott Laboratories

ABT | NYSE
Chart Builder DCF Calculator
$102.88
+$0.27 (+0.26%)
Sep 21, 2026, 12:40 PM ET · Market open

Company Profile

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Key Executives

Name Position
Robert Ford Executive Chairman & CEO
Philip Boudreau Chief Financial Officer & Executive Vice President of Finance
Sabina Ewing Senior Vice President of Business & Technology Services and Chief Information Officer
Christopher J. Scoggins Executive Vice President of Diabetes Care
Daniel Gesua Sive Salvadori Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products
Elizabeth Cushman Executive Vice President, General Counsel & Secretary
Erica L. Battaglia Vice President and Chief Ethics & Compliance Officer
Lisa D. Earnhardt Executive Vice President & Group President of Medical Devices
Mary K. Moreland Executive Vice President of Human Resources
Melissa Brotz Senior Vice President of Global Marketing & External Affairs
Michael Comilla Vice President of Investor Relations.

Latest SEC Filings

Date Type Title
Sep 03, 2026 4 Filing
Sep 03, 2026 4 Filing
Aug 27, 2026 4 Filing
Aug 20, 2026 8-K Current Report
Aug 13, 2026 4 Filing
Jul 28, 2026 10-Q Quarterly Report
Jul 16, 2026 8-K Current Report
Jul 01, 2026 4 Filing
Jul 01, 2026 4 Filing
Jul 01, 2026 4 Filing
View All SEC Filings
Abbott Laboratories
Abbott Laboratories logo
Country United States
IPO Date Mar 16, 1980
Industry Medical - Devices
Sector Healthcare
Employees 115,000
CEO Robert Ford

Contact Details

100 Abbott Park Road Abbott Park, Illinois 60064-6400 United States

Stock Details

Ticker Symbol ABT
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000001800
CUSIP Number 002824100
ISIN Number US0028241000
SIC Code 2834

© 2026 bestshares.com. All rights reserved.